http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1119600-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fc7579c41844aa7b89575ca6a31bffc |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27 |
filingDate | 1979-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1982-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f928652f64510ba2a4938064deb1386 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9abc87937bd0a3893a387496851ee053 |
publicationDate | 1982-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1119600-A |
titleOfInvention | (2-oxo-pyrrolidine-1) and (2-oxo-piperidine-1) carboxylic-acid derivatives, a method for producing them and pharmaceutical preparations containing them |
abstract | ABSTRACT OF THE DISCLOSURE The invention relates to new (2-oxo-pyrrolidine-1)-carboxylic-acid hydrazides, (2-oxo-piperidine-1)-carboxylic-acid hydrazides, (2-oxo-pyrrolidine-1) carboxylic-acid esters, and (2-oxo-piperidine-1)-carboxylic-acid esters, and to pharmaceutically compatible salts thereof. The new compounds exhibit superior pharmacological effectiveness and, at the same time, extremely low toxicity. They act, for example, as psychopharmaca, against retrograde and anterograde amnesia, ischemias of various origins and also have a nootropic action. |
priorityDate | 1979-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.